Health and Science
Scientists have mapped CB1, the human receptor that binds with cannabis, Wired reports:
“For a long time, scientists thought CB1 receptors worked like lock and key with THC and its chemical cousins—one size fits one. However, new research shows that CB1 receptors are actually quite malleable, stretching to fit a wider range of molecules. That could be useful knowledge as researchers try to synthesize chemicals that mimic the desirable effects of cannabis (such as pain relief) without the side effects (such as anxiety, weight gain, addiction, or federal prosecution).”
Scientists called out the web site Salon.com for publishing a misleading article on cannabis. The article, which originally appeared at the cannabis site The Fresh Toast, claimed a study by Oregon Health and Science University researchers found cannabis users to have lower body mass index (BMI) than non-users.
The researchers were actually studying the relationship between cannabis use and bone mineral density and said the BMI data was taken out of context in the headline “Science: Regular consumption of marijuana keeps you thin fit and active.” The researchers found no correlation between cannabis use and bone mineral density. (Disclosure: I used to work for Salon.)
Almost a year after the DEA said it would make MED research easier, a facility at the University of Mississippi remains the only federally permitted grow.
Some psychiatrists consider pot a psychoactive.
The number of U.S. opioid prescriptions declined slightly between 2012 and 2015, a “glimmer of hope” in efforts against the crisis.
New York Gov. Andrew Cuomo (D) is under pressure from veterans groups to add PTSD as a qualifying condition for MED.
Canadian MED producer Canopy Growth is funding a MED research program at the Canadian AIDS society.
An anti-drug and gang group in Carlsbad, New Mexico objects to dispensaries using the word “pharmaceutical” in their name.